Today, Biosense Webster, a division of Johnson & Johnson MedTech, announced the release of the most recent iteration of its Carto 3 cardiac mapping system.
Heart mapping in three dimensions is available for cardiac ablation procedures with Carto 3 Version 8. It is integrated by Biosense Webster into technology such as the FDA-reviewed Varipulse pulsed field ablation (PFA) system.
Carto Elevate and CartoSound FAM are two new modules that Biosense Webster added to the software. These modules were created by the company to be accurate, efficient, and repeatable when used in catheter ablation procedures for arrhythmias such as AFib.
Biosense Webster’s CartoSound FAM encompasses the first application of artificial intelligence in intracardiac ultrasound. In addition to saving time, the algorithm, according to the company, provides a highly accurate map by automatically generating the left atrial anatomy prior to the catheter being inserted into the left atrium. Through the use of deep learning technology, the module produces 3D shells automatically.
Incorporating multipolar capabilities with the Optrell mapping catheter is one of the new features of the Carto Elevate module. By doing so, far-field potentials are greatly reduced and a more precise activation map for localized unipolar signals is produced. The identification of crucial areas of interest is done effectively and consistently with Elevate’s complex signals identification. An improved Confidense module generates optimal maps, and pattern acquisition automatically monitors arrhythmia burden prior to and following ablation.
Jasmina Brooks, president of Biosense Webster, stated, “We are happy to announce this new version of our Carto 3 system, which reflects our continued focus on harnessing the latest science and technology to advance tools for electrophysiologists to treat cardiac arrhythmias.” For over a decade, the Carto 3 system has served as the mainstay of catheter ablation procedures, assisting electrophysiologists in their decision-making regarding patient care. With the use of ultrasound technology, better substrate characterization, and improved signal analysis, this new version improves the mapping and ablation experience of Carto 3.